These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 32051330)

  • 1. Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis.
    Leung KL; Fong W; Freedman B; Bajorek B; Lee VWY
    Hong Kong Med J; 2020 Feb; 26(1):27-34. PubMed ID: 32051330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients.
    Zhang JL; Zheng X; Zou DJ; Qiu JL; Zhao XX; Qin YW
    Am J Hypertens; 2009 Aug; 22(8):884-90. PubMed ID: 19574961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: a cohort study.
    Wong MC; Tam WW; Lao XQ; Wang HH; Kwan MW; Cheung CS; Tong EL; Cheung NT; Yan BP; Yu CM; Griffiths SM
    Int J Cardiol; 2014 Aug; 175(3):425-32. PubMed ID: 24986230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
    Ripley TL; Saseen JJ
    Ann Pharmacother; 2014 Jun; 48(6):723-33. PubMed ID: 24687542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative β-blockade: atenolol is associated with reduced mortality when compared to metoprolol.
    Wallace AW; Au S; Cason BA
    Anesthesiology; 2011 Apr; 114(4):824-36. PubMed ID: 21372680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of beta-blockers in obesity hypertension: potential role of weight gain.
    Pischon T; Sharma AM
    Obes Rev; 2001 Nov; 2(4):275-80. PubMed ID: 12119998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index profile in Hong Kong Chinese adults.
    Ko GT; Wu MM; Tang J; Wai HP; Chan CH; Chen R
    Ann Acad Med Singap; 2001 Jul; 30(4):393-6. PubMed ID: 11503547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.
    Wong MC; Jiang JY; Griffiths SM
    Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis.
    Kuyper LM; Khan NA
    Can J Cardiol; 2014 May; 30(5 Suppl):S47-53. PubMed ID: 24750981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
    Jordan J; Engeli S; Boschmann M; Weidinger G; Luft FC; Sharma AM; Kreuzberg U
    J Hypertens; 2005 Dec; 23(12):2313-8. PubMed ID: 16269974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker subtypes and risk of low birth weight in newborns.
    Duan L; Ng A; Chen W; Spencer HT; Lee MS
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric profile of Hong Kong children and adolescents: the Wellness Population of Youth Study.
    Lee RLT; Lee PH; Sze DMY; Chien WT
    J Am Soc Hypertens; 2017 Apr; 11(4):196-203.e4. PubMed ID: 28242179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and cardiovascular risk factors in Hong Kong Chinese.
    Lee ZS; Critchley JA; Ko GT; Anderson PJ; Thomas GN; Young RP; Chan TY; Cockram CS; Tomlinson B; Chan JC
    Obes Rev; 2002 Aug; 3(3):173-82. PubMed ID: 12164469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of different initial beta blockers on treatment persistence: atenolol vs new-generation beta blocker, a population-based study.
    Choi YJ; Ah YM; Kong J; Choi KH; Kim B; Han N; Yu YM; Oh JM; Shin WG; Lee HY; Lee JY
    Cardiovasc Ther; 2016 Aug; 34(4):268-75. PubMed ID: 27214564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol in hypertension: is it a wise choice?
    Carlberg B; Samuelsson O; Lindholm LH
    Lancet; 2004 Nov 6-12; 364(9446):1684-9. PubMed ID: 15530629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.